Jon Linkous is CEO of the American Telemedicine Association (ATA; Washington), which bills itself as the largest membership-based organization in the world focusing exclusively on providing health and medical care through telecommunications technology. He has spoken and written extensively in the U.S. and in other countries on policy issues, emerging applications and market trends affecting telemedicine. Linkous has more than 20 years of experience in the nation's capital working in corporate and public sectors.
Michael Coppola, MD, is chief medical officer and VP of medical affairs for NovaSom (Glen Burnie, Maryland). He also serves as president of the American Sleep Apnea Association, a patient advocacy group. Of obstructive sleep apnea, he says, "It's a big area, certainly one of the largest health problems in the United States."
Michael Coppola, MD, is chief medical officer and VP of medical affairs for NovaSom (Glen Burnie, Maryland). He also serves as president of the American Sleep Apnea Association, a patient advocacy group. Of obstructive sleep apnea, he says, "It's a big area, certainly one of the largest health problems in the United States."
Oscar Pistorius didn’t win a medal in the just-concluded Olympic Games. Not a gold, not a silver, not a bronze. In fact, he finished last in his semifinal heat of the 400-meter run (I think they call it the 400-meter dash, although I can’t fathom any race that requires one full lap around the track being called a dash), and his South African relay team finished next-to-last in the finals of that event. But the 25-year-old Pistorius leaves quite a legacy behind in London, and not just because he became the first double-amputee athlete to compete against normal, able-bodied athletes...
David B. Nash, MD, was named the founding dean of the Jefferson School of Population Health (JSPH; Philadelphia) in 2008, following an 18-year tenure on the faculty of Jefferson Medical College. JSPH provides innovative educational programming designed to develop healthcare leaders for the future. Its offerings include masters programs in public health, healthcare quality and safety, health policy and applied health economics. JSPH also offers a doctoral program in population health science.
Mara Aspinall is president of Ventana Medical Systems (Tucson, Arizona), a maker of tissue-based cancer diagnostics and a member of the Roche Group. Prior to joining Ventana in September 2011, she was founder, president, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology. Prior to that, Aspinall spent 12 years with Genzyme, where she held senior leadership roles such as president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
Mara Aspinall is president of Ventana Medical Systems (Tucson, Arizona), a maker of tissue-based cancer diagnostics and a member of the Roche Group. Prior to joining Ventana in September 2011, she was founder, president/CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology. Prior to that, Aspinall spent 12 years with Genzyme, where she held senior leadership roles as president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
Julie McHugh was appointed chief operating officer of Endo Health Solutions (Chadds Ford, Pennsylvania) in March 2010. Prior to joining Endo, she was CEO of Nora Therapeutics, a venture-backed biotech company focused on the treatment of infertility disorders.
Julie McHugh was appointed chief operating officer of Endo Health Solutions (Chadds Ford, Pennsylvania) in March 2010. Prior to joining Endo, she was CEO of Nora Therapeutics, a venture-backed biotech company focused on the treatment of infertility disorders.
Arthur Erdman, PhD, is the Richard C. Jordan Professor and a Morse Alumni Distinguished Teaching Professor of Mechanical Engineering at the University of Minnesota, specializing in mechanical design, bioengineering and product design. In July 2007 he was selected as the Director of the Medical Devices Center at the university. Erdman has published more than 325 technical papers, three books, holds over 30 patents, and shares with his former students nine Best Paper Awards at international conferences.